PLEK2 was found to be upregulated in different subgroups of HNSCC (Figure 3A–L, Table S2), suggesting that PLEK2 might be a potential diagnostic marker for HNSCC patients. This evidence concerns the gene PLEK2 and head and neck squamous cell carcinoma.